Humira (adalimumab) 40 mg/0.4 mL Injection In Pakistan

Humira® (Adalimumab) 40 mg/0.4 mL Injection in Pakistan

Humira® 40 mg/0.4 mL Injection contains adalimumab, a biologic medicine that belongs to the class of TNF (tumor necrosis factor) blockers. It is used to reduce inflammation and control several chronic inflammatory and autoimmune conditions. The 40 mg/0.4 mL presentation is supplied as a single-dose pre-filled pen or pre-filled syringe.

Active Ingredient

• Brand: Humira®
• Active ingredient: Adalimumab
• Strength: 40 mg/0.4 mL
• Concentration: 100 mg/mL
• Dosage form: Solution for injection
• Route: Subcutaneous injection
• Presentation: Pre-filled pen or pre-filled syringe

Uses

Humira® may be prescribed for several inflammatory conditions, including:

• Rheumatoid arthritis
• Psoriatic arthritis
• Ankylosing spondylitis and other axial spondyloarthritis
• Plaque psoriasis
• Crohn's disease
• Ulcerative colitis
• Hidradenitis suppurativa
• Certain forms of juvenile idiopathic arthritis
• Uveitis

The approved uses can vary according to the patient's age and the regulatory approval applicable in the country.

How Does Humira® Work?

Adalimumab is a TNF-alpha inhibitor. It binds to TNF-α, an inflammatory protein involved in the body's immune response, thereby reducing excessive inflammation associated with several autoimmune and inflammatory diseases.

Dosage & Administration

Humira® is administered by subcutaneous injection. The dose and injection schedule depend on the condition being treated, the patient's age, and the doctor's treatment plan.

Patients using the pre-filled pen or syringe should receive appropriate instructions from their healthcare professional before self-administration. Do not change the dose or frequency without medical advice.

Important Safety Information

Because Humira® suppresses part of the immune system, it can increase the risk of serious infections. Doctors may evaluate patients for certain infections, including tuberculosis, before and during treatment.

Patients should inform their healthcare provider about persistent fever, cough, unusual infections, or other signs of infection.

Possible Side Effects

Possible side effects include:

• Injection-site reactions
• Headache
• Nausea
• Upper respiratory tract infections
• Abdominal discomfort
• Rash

More serious infections and other immune-related complications can occur. Seek medical attention for severe or persistent symptoms.

Storage

Humira® should generally be stored in a refrigerator at 2°C–8°C and protected from light in its original carton. Do not freeze. If necessary, Humira® may be kept at room temperature up to 25°C for a maximum of 14 days, after which it should be discarded if unused.

Availability in Pakistan

Humira® 40 mg/0.4 mL Injection is available through medicine suppliers and pharmacies in Pakistan, subject to current stock and prescription requirements. Pakistani online pharmacy listings currently show the 40 mg/0.4 mL presentation.

Availability Across Pakistan

Available in Lahore, Karachi, Islamabad, Bahawalpur, Peshawar, Multan, Gujranwala, Rawalpindi, Hyderabad, Faisalabad, Larkana, Sukkur, Sialkot, and other major cities of Pakistan, subject to availability and cold-chain requirements.

Prescription Information

Humira® is a prescription biologic medicine and should be used under the supervision of a qualified doctor or specialist. It should be obtained from a licensed pharmacy or authorized medicine supplier.